The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

incred.com

Founded Year

2016

Stage

Debt - III | Alive

Total Raised

$273.57M

Last Raised

$67M | 2 yrs ago

About InCred

InCred is a technology-led financial services company focusing on SME loans, consumer/personal loans, home loans, and education loans.

InCred Headquarter Location

1502, The Capital Bandra Kurla Complex

Mumbai, 400051,

India

+91-1860 500 2192

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing InCred

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned InCred in 1 CB Insights research brief, most recently on Mar 15, 2022.

Expert Collections containing InCred

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

InCred is included in 4 Expert Collections, including Mortgage Tech.

M

Mortgage Tech

218 items

Companies here streamline and digitize the mortgage lending process. Collection includes direct lenders, mortgage brokers, process optimization technologies for lenders, as well as tools that support borrowers throughout the search and application phases.

D

Digital Lending

1,550 items

This collection contains companies that provide alternative means for obtaining a loan for personal or business use and companies that provide software to lenders for the application, underwriting, funding or loan collection process.

S

SMB Fintech

1,145 items

F

Fintech

3,495 items

Latest InCred News

InCred’s Aditya Khemka On A ‘Well-Made’ Healthcare Portfolio, And His Top Bets

Jun 22, 2022

9:59 AM IST, 22 Jun 2022 9:00 AM IST, 22 Jun 2022 9:59 AM IST, 22 Jun 2022 Save A “well-made healthcare portfolio” can help tide over the impact of inflation and rising interest rates, according to Aditya Khemka, fund manager at InCred Healthcare Fund.InCred has invested 45% of its healthcare funds in branded generics, 20% each in hospitals and API manufacturing companies, and 5% in diagnostics, he told BQ Prime’s Niraj Shah in an interview. The rest comprises 7% exposure in unbranded generics and 3% cash.Unbran... A “well-made healthcare portfolio” can help tide over the impact of inflation and rising interest rates, according to Aditya Khemka, fund manager at InCred Healthcare Fund. InCred has invested 45% of its healthcare funds in branded generics, 20% each in hospitals and API manufacturing companies, and 5% in diagnostics, he told BQ Prime’s Niraj Shah in an interview. The rest comprises 7% exposure in unbranded generics and 3% cash. Unbranded generics, Khemka said, are like any other “commodity” where whoever can sell the cheapest gets the highest volume but at the cost of margins. Since demand for unbranded generics in markets like the US is stable, supply would be the price-driver. According to him, “there is more and more supply hitting the market” and therefore, “he does not see the pricing improving”. Branded Generics Branded generics have the most stable risk-reward ratio, and are Khemka’s top bet. This is followed by hospitals, diagnostics and APIs. Active pharmaceutical ingredients, he said, have the highest risk-reward ratio. Branded generics is a hold-to-maturity business, Khemka said. “While the branded generics business in India is extremely competitive, it is also extremely profitable.” But it takes 8-10 years to build a brand and the company must have the money to stick through that period, he said. According to Khemka, it's the only sector where large companies have lower return-on-equity than smaller companies. The reason, he said, was that a small company may only be doing branded generics, while a large firm may have unbranded, branded and APIs. Hospitals The hospital business, Khemka said, is similar to branded generics where people go for the brand of the hospital and the doctors, building loyalty. Superspecialty hospitals are his top bet in the segment. Across the globe, superspecialty companies are valued higher than multispecialty companies, he said. “It is only in India right now that super-specialty hospitals are available cheaper than multispecialty hospitals.” While multispecialty hospitals enjoy scale and are being preferred by investors, a superspecialty hospital’s audience is “extremely sticky”. The perception towards superspecialty hospitals, he said, is changing. “One should focus on cash flows when the business is asset-heavy.” Except for FMCG, the only other business that has a negative working capital is hospitals, he said. “A negative working capital means absolute bargaining power where customer is at your mercy and you can ask them to pay sooner, while you can pay your vendors later.” Diagnostics As competition intensifies with some chains offering discounted pricing, Khemka said “diagnostics is a branded play; there is quality attached to it, perception attached to it and acceptability attached to it. If the doctor does not accept the report and asks it to be redone, then what use is the low price”. Khemka, along with portfolio manager Marcellus Investors, acknowledged that on ground, competitive pressures resulting in pricing erosion or lower business is not evident. The non-covid business for the listed diagnostic companies is recovering, he said. “If competition were the key factor impacting these companies, then growth in the non-covid space would not have happened and the business would have gone to new players.” Since 85% of the diagnostic market is unorganised, “there is enough space for new players to come and cannibalise the unorganised market share”, Khemka said. ALSO READ

InCred Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

InCred Rank

  • When was InCred founded?

    InCred was founded in 2016.

  • Where is InCred's headquarters?

    InCred's headquarters is located at 1502, The Capital, Mumbai.

  • What is InCred's latest funding round?

    InCred's latest funding round is Debt - III.

  • How much did InCred raise?

    InCred raised a total of $273.57M.

  • Who are the investors of InCred?

    Investors of InCred include Alpha Capital Advisors, Elevar Equity, FMO, Moore Capital Management, Paragon Partners (India) and 5 more.

  • Who are InCred's competitors?

    Competitors of InCred include MyShubhLife and 3 more.

You May Also Like

SMEcorner Logo
SMEcorner

SMEcorner offers quick access to business loans to micro, small and medium enterprises (MSME) and runs two products under its portfolio-unsecured business loans and loans against property.

LoanTap Logo
LoanTap

LoanTap is an online platform committed to deliver customized loan products.

I
Ice Kredit

IceKredit is an AI company providing business-level services with its Artificial Intelligence technologies. Since founded in 2015, IceKredit has become an AI service provider with a focus on credit risk management for both individuals and financial institutions while constantly expanding its AI technologies to more sectors including medical care, government events, and public security.

Behalf Logo
Behalf

Behalf is a financing provider that facilitates commerce between business to business vendors and their small and medium business customers. Driven by data and technology, Behalf allows vendor partners to offer business customers instant credit and flexible payment terms at the point of sale.

K
KarmaLife

KarmaLife provides a financial services suite enabling India’s growing population of gig and essential services workers to smooth uneven cash flows, stabilize incomes, and access savings and insurance.

Funding Societies Logo
Funding Societies

Funding Societies (aka Modalku) is a Southeast Asia SME digital financing platform. It is licensed in Singapore and provides business financing to small and medium-sized enterprises (SMEs), which is funded by individual and institutional investors.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.